Brain cell transplant aims to restore movement in Parkinson's patients
Disease control
Not yet recruiting
This early-stage trial tests whether injecting lab-grown dopamine-producing cells into the brain is safe for people with advanced Parkinson's disease. The study involves 12 participants aged 55-75 who have had Parkinson's for over 5 years and experience medication complications. …
Phase: PHASE1 • Sponsor: iCamuno Biotherapeutics Ltd. • Aim: Disease control
Last updated May 07, 2026 18:41 UTC